Published in Circ Res on March 04, 2011
PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol (2012) 2.39
Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov (2011) 1.78
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. Circ Res (2012) 1.29
Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21
Design, construction, and validation of a rotary multifunctional intravascular diagnostic catheter combining multispectral fluorescence lifetime imaging and intravascular ultrasound. J Biomed Opt (2012) 1.12
Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc Natl Acad Sci U S A (2012) 1.09
Molecular imaging of inflammation in atherosclerosis. Theranostics (2013) 1.08
Mechanisms of load dependency of myocardial ischemia reperfusion injury. Am J Cardiovasc Dis (2013) 1.06
The spatial and developmental relationships in the macrophage family. Arterioscler Thromb Vasc Biol (2011) 1.02
Radiolabelled probes for imaging of atherosclerotic plaques. Am J Nucl Med Mol Imaging (2012) 0.93
High-resolution visualization of mouse cardiac microvasculature using optical histology. Biomed Opt Express (2013) 0.92
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. AJR Am J Roentgenol (2015) 0.91
Multimodality imaging in interventional cardiology. Nat Rev Cardiol (2012) 0.87
Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent. J Nanobiotechnology (2012) 0.87
Positron emission tomography imaging of atherosclerosis. Theranostics (2013) 0.87
Silencing of CCR2 in myocarditis. Eur Heart J (2014) 0.86
Cardiovascular imaging: a glimpse into the future. Methodist Debakey Cardiovasc J (2015) 0.86
Imaging systemic inflammatory networks in ischemic heart disease. J Am Coll Cardiol (2015) 0.84
Cardioprotective C-kit⁺ bone marrow cells attenuate apoptosis after acute myocardial infarction in mice - in-vivo assessment with fluorescence molecular imaging. Theranostics (2013) 0.84
Interaction between drug delivery vehicles and cells under the effect of shear stress. Biomicrofluidics (2015) 0.83
Molecular MRI of Inflammation in Atherosclerosis. Curr Cardiovasc Imaging Rep (2011) 0.81
Molecular imaging of plaques in coronary arteries with PET and SPECT. J Geriatr Cardiol (2014) 0.79
Imaging macrophage development and fate in atherosclerosis and myocardial infarction. Immunol Cell Biol (2012) 0.79
Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis. Theranostics (2016) 0.79
Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed (2012) 0.78
Noninvasive detection of macrophages in atheroma using a radiocontrast-loaded phosphatidylserine-containing liposomal contrast agent for computed tomography. Mol Imaging Biol (2015) 0.78
Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles. J Control Release (2015) 0.77
Design of nanovectors for therapy and imaging of cardiovascular diseases. Methodist Debakey Cardiovasc J (2012) 0.77
Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging. Theranostics (2015) 0.76
Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification. Circ Cardiovasc Imaging (2012) 0.75
Detection and treatment of atherosclerosis using nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.75
F-18 labeled vasoactive intestinal peptide analogue in the PET imaging of colon carcinoma in nude mice. Biomed Res Int (2013) 0.75
Integrating nanomedicine and imaging. Philos Trans A Math Phys Eng Sci (2017) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Inflammation in atherosclerosis. Nature (2002) 28.92
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Quantum dots for live cells, in vivo imaging, and diagnostics. Science (2005) 21.62
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Imaging in the era of molecular oncology. Nature (2008) 11.10
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Shedding light onto live molecular targets. Nat Med (2003) 8.47
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79
Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods (2010) 5.65
Imaging of angiogenesis: from microscope to clinic. Nat Med (2003) 5.51
Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med (1997) 5.09
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev (2007) 4.69
Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science (2009) 4.67
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med (2008) 4.54
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
Imaging of atherosclerotic cardiovascular disease. Nature (2008) 4.14
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85
Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet (2000) 3.71
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res (2005) 3.71
Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation (2003) 3.68
Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation (2003) 3.58
Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation (2006) 3.57
Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol (2009) 3.44
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med (2007) 3.40
Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation (2010) 3.37
Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol (2007) 2.91
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 2.82
Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res (2007) 2.77
Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65
In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62
In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation (2008) 2.57
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol (2003) 2.54
Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52
Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci U S A (2008) 2.50
Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation (2005) 2.45
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology (2010) 2.43
Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation (2007) 2.40
Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging (2010) 2.38
Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med (2009) 2.21
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging (2009) 2.17
Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci U S A (2010) 2.17
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol (2009) 2.15
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol (2010) 2.07
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest (2004) 2.06
Healing after myocardial infarction. Cardiovasc Res (2005) 2.05
Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med (2005) 2.03
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol (2008) 1.97
Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation (2008) 1.97
Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol (2009) 1.93
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation (2005) 1.82
Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res (2010) 1.82
Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology (2006) 1.79
18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjug Chem (2009) 1.78
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol (2009) 1.76
Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew Chem Int Ed Engl (2007) 1.75
Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation (2008) 1.68
Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol (2005) 1.67
Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC Cardiovasc Imaging (2008) 1.67
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction. Eur Heart J (2008) 1.62
Hybrid system for simultaneous fluorescence and x-ray computed tomography. IEEE Trans Med Imaging (2009) 1.62
Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation (2006) 1.61
Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation (2006) 1.60
Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation (2004) 1.57
Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo. Circulation (2004) 1.57
Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol (2008) 1.55
Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation (2010) 1.53
Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology (2008) 1.48
Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest (2010) 1.48
The vulnerable atherosclerotic plaque: scope of the literature. Ann Intern Med (2010) 1.40
Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc Ther (2010) 1.39
Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation (2008) 1.37
Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation (2002) 1.34
Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circ Cardiovasc Imaging (2009) 1.30
Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation (2008) 1.28
Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation (2009) 1.26
Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging (2009) 1.21
Coronary magnetic resonance angiography. J Magn Reson Imaging (2007) 1.18
Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circ Cardiovasc Imaging (2009) 1.16
In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction. Eur Heart J (2008) 1.14
Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med (2007) 1.08
Progression and disruption of advanced atherosclerotic plaques in murine models. Curr Drug Targets (2008) 1.07
Imaging of the unstable plaque: how far have we got? Eur Heart J (2009) 1.06
Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol (2006) 1.02
A DNA-binding Gd chelate for the detection of cell death by MRI. Chem Commun (Camb) (2009) 1.02
Radionuclide imaging of myocardial metabolism. Circ Cardiovasc Imaging (2010) 1.02
Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis. Magn Reson Med (2008) 1.01
Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation (1998) 1.01
Near-infrared fluorescence catheter system for two-dimensional intravascular imaging in vivo. Opt Express (2010) 1.01
Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. JACC Cardiovasc Imaging (2009) 0.99
Advances in clinical applications of cardiovascular magnetic resonance imaging. Heart (2008) 0.96
Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arterioscler Thromb Vasc Biol (2010) 0.95
Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation. J Am Chem Soc (2009) 0.95
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45
Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A (2012) 2.42
PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol (2012) 2.39
Programming human pluripotent stem cells into white and brown adipocytes. Nat Cell Biol (2012) 2.26
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat Biotechnol (2013) 2.11
Innate response activator B cells protect against microbial sepsis. Science (2012) 2.07
Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med (2005) 2.03
Angiotensin II drives the production of tumor-promoting macrophages. Immunity (2013) 1.88
Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J (2013) 1.83
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res (2010) 1.82
Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res (2014) 1.78
18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjug Chem (2009) 1.78
Intraoperative near-infrared fluorescent cholangiography (NIRFC) in mouse models of bile duct injury. World J Surg (2010) 1.67
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res (2005) 1.66
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci U S A (2007) 1.65
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol (2008) 1.60
Real-time in vivo imaging of the beating mouse heart at microscopic resolution. Nat Commun (2012) 1.58
Molecular magnetic resonance imaging in cardiovascular medicine. Circulation (2007) 1.54
In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol (2006) 1.51
Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging (2006) 1.48
Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest (2010) 1.48
In vivo assessment of absolute perfusion in the murine skeletal muscle with spin labeling MRI. Magnetic resonance imaging. J Magn Reson Imaging (2003) 1.45
Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation. J Clin Invest (2008) 1.43
Tracheal tube obstruction in mechanically ventilated patients assessed by high-resolution computed tomography. Anesthesiology (2014) 1.41
Novel insights into LV remodeling after murine myocardial infarction by in vivo magnetic resonance tissue velocity mapping. Int J Cardiovasc Imaging (2004) 1.39
In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med (2011) 1.38
Molecular imaging of innate immune cell function in transplant rejection. Circulation (2009) 1.34
Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J (2012) 1.31
In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn Reson Med (2005) 1.31
Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circ Cardiovasc Imaging (2009) 1.30
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation (2013) 1.30
Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. Neoplasia (2009) 1.28
Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging (2008) 1.25
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells. Mol Ther Nucleic Acids (2012) 1.24
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation (2011) 1.23
Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21
Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors. PLoS One (2009) 1.20
Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep (2012) 1.19
Normalized Born ratio for fluorescence optical projection tomography. Opt Lett (2009) 1.17
Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circ Cardiovasc Imaging (2009) 1.16
89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjug Chem (2011) 1.14
Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res (2013) 1.11
Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models. PLoS One (2010) 1.10
Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. Circulation (2008) 1.10
Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc Natl Acad Sci U S A (2012) 1.09
Imaging of the unstable plaque: how far have we got? Eur Heart J (2009) 1.06
Monocyte heterogeneity in cardiovascular disease. Semin Immunopathol (2013) 1.05
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett (2012) 1.02
Nanoparticle-based monitoring of cell therapy. Nanotechnology (2011) 1.01
Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials (2010) 1.01
Volume catheter parallel conductance varies between end-systole and end-diastole. IEEE Trans Biomed Eng (2007) 1.00
In vivo time-resolved quantitative motion mapping of the murine myocardium with phase contrast MRI. Magn Reson Med (2003) 1.00
High throughput transmission optical projection tomography using low cost graphics processing unit. Opt Express (2009) 1.00
Molecular imaging of myocardial infarction. J Mol Cell Cardiol (2006) 0.99
Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation (2014) 0.99
Targeted imaging of myocardial damage. Nat Clin Pract Cardiovasc Med (2008) 0.97
Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation. J Am Chem Soc (2009) 0.95
Cardiac MRI in mice at 9.4 Tesla with a transmit-receive surface coil and a cardiac-tailored intensity-correction algorithm. J Magn Reson Imaging (2007) 0.94
Feasibility of real-time MRI with a novel carbon catheter for interventional electrophysiology. Circ Arrhythm Electrophysiol (2009) 0.93
Sequential average segmented microscopy for high signal-to-noise ratio motion-artifact-free in vivo heart imaging. Biomed Opt Express (2013) 0.93
Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries. Integr Biol (Camb) (2009) 0.91
Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol Imaging (2006) 0.90
Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell-selectin interaction kinetics. Biomaterials (2012) 0.89
Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. Expert Rev Mol Diagn (2013) 0.88
Healing and adverse remodelling after acute myocardial infarction: role of the cellular immune response. Heart (2012) 0.86
Cardiovascular molecular imaging: the road ahead. J Nucl Med (2012) 0.86
Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway. JACC Cardiovasc Imaging (2012) 0.84
Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts. Circ Cardiovasc Imaging (2013) 0.84
Will molecular optical imaging have clinically important roles in stroke management, and how? J Clin Neurol (2010) 0.84
Born normalization for fluorescence optical projection tomography for whole heart imaging. J Vis Exp (2009) 0.84
The ins and outs of inflammatory cells in atheromata. Cell Metab (2012) 0.84
Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarction. Circulation (2012) 0.83
Direct thrombus imaging as a means to control the variability of mouse embolic infarct models: the role of optical molecular imaging. Stroke (2011) 0.83
Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ Cardiovasc Imaging (2013) 0.83
Feasibility of contrast-enhanced and nonenhanced MRI for intraprocedural and postprocedural lesion visualization in interventional electrophysiology: animal studies and early delineation of isthmus ablation lesions in patients with typical atrial flutter. Circ Cardiovasc Imaging (2011) 0.83
Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque. Atherosclerosis (2011) 0.83
Molecular imaging of atherosclerosis: a progress report. Tex Heart Inst J (2010) 0.82
Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction. Circ Cardiovasc Imaging (2012) 0.82
Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase. Radiology (2011) 0.81
Intraoperative near-infrared fluorescent cholangiography (NIRFC) in mouse models of bile duct injury: reply. World J Surg (2011) 0.81
The journey from stem cell to macrophage. Ann N Y Acad Sci (2014) 0.81
MRI of a novel murine working heart transplant model. Circ Heart Fail (2009) 0.81
Regulation and consequences of monocytosis. Immunol Rev (2014) 0.79
Imaging macrophage development and fate in atherosclerosis and myocardial infarction. Immunol Cell Biol (2012) 0.79
Endocarditis and molecular imaging. J Nucl Cardiol (2014) 0.79
Macrophage-stem cell crosstalk after myocardial infarction. J Am Coll Cardiol (2013) 0.78
Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed (2012) 0.78
Mapping molecular agents distributions in whole mice hearts using born-normalized optical projection tomography. PLoS One (2012) 0.77
Macrophages in the infarct: fiery friends or friendly fire? J Mol Cell Cardiol (2012) 0.77